FDAFDA · Food and drugs·Recall number D-0093-2022
Cubicin (daptomycin for injection), 500 mg per vial, Single-dose vial, Rx only. Manuf. for: Merck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc., Whitehouse Station, NJ 08889, USA. Manuf. by: Baxter Pharmaceuticals LLC., Bloomington, IN 47403, USA, NDC: 67919-011-01
Published November 10, 2021 · Recall initiated: October 19, 2021
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Presence of Particulate Matter: Identified as Glass Particles
What to do
Voluntary: Firm initiated · Press Release
Recall details
- Manufacturer
- MERCK SHARP & DOHME CORP
- Distributor
- Nationwide within the United States
- Lot
- Lot #: 934778, Exp. Date Jun 2022
- Risk classification
- Class I
- Area (FDA)
- drug
- Country
- United States
Sell products like this?
Recalert watches your whole catalog for recalls like this one, automatically.